Clinical Trial Details

NODE 302

NODE 302: Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia the NODE-302 trial (Extension of NODE-301)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Paroxysmal supraventricular tachycardia (PSVT)
Study Type: Interventional
Phase: Phase III
Study Start Date: 12/10/2018
Study Completion Date: 12/2021

This study is an extension of the NODE-301 efficacy study to evaluate the safety of etripamil NS 70 mg when self-administered by patients for spontaneous episodes of PSVT in an outpatient setting

NCT Number

NCT03635996

Principal Investigator(s)

Sean Beinart, MD

Sponsor(s)

Milestone Pharmaceuticals

Participant Eligibility

• Age: 18 years and older
• Gender: Male, Female